PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations

Inhibition of the PD-1/PD-L1 pathway may induce anticancer immune responses in non-small cell lung cancer (NSCLC). Two PD-L1 immunohistochemistry (IHC) assays have been approved as companion diagnostic tests for therapeutic anti-PD-1 antibodies. However, many aspects of PD-L1 prevalence and associat...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Scheel, Andreas H., Ansén, Sascha, Schultheis, Anne M., Scheffler, Matthias, Fischer, Rieke N., Michels, Sebastian, Hellmich, Martin, George, Julie, Zander, Thomas, Brockmann, Michael, Stoelben, Erich, Groen, Harry, Timens, Wim, Perner, Sven, von Bergwelt-Baildon, Michael, Büttner, Reinhard, Wolf, Jürgen
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2016
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910698/
https://ncbi.nlm.nih.gov/pubmed/27467949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1131379
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items